Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan

[1]  Hirokazu Takahashi,et al.  Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria , 2009, Digestive Diseases and Sciences.

[2]  T. Rokkas,et al.  Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  P. Hainaut,et al.  Epidemiology of oesophagogastric cancer , 2007 .

[4]  E. Cutsem.  The multidisciplinary management of gastrointestinal cancer , 2007 .

[5]  T. Shimosegawa,et al.  Extensive Gastric Atrophy: An Increased Risk Factor for Superficial Esophageal Squamous Cell Carcinoma in Japan , 2007, The American Journal of Gastroenterology.

[6]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[7]  N. Ishimura,et al.  Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype , 2006, Scandinavian journal of gastroenterology.

[8]  Jang-Ming Lee,et al.  Helicobacter pylori Infection: A Protective Factor for Esophageal Squamous Cell Carcinoma in a Taiwanese Population , 2005, The American Journal of Gastroenterology.

[9]  Joseph K McLaughlin,et al.  Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.

[10]  C. Hamashima,et al.  Mortality trend of esophageal cancer in Japan: 1960-2000. , 2003, Japanese journal of clinical oncology.

[11]  M. Hongo.  Nocturnal gastric acid breakthrough may not be a problem of acid secretion only , 2003, Journal of Gastroenterology.

[12]  J. Virtamo,et al.  Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  M. Hongo,et al.  Epidemiology of reflux disease and CLE in East Asia. , 2002, Journal of gastroenterology.

[14]  G. Berglund,et al.  Helicobacter pylori Infection is Associated with a Decreased Risk of Developing Oesophageal Neoplasms , 2001, Helicobacter.

[15]  L. Hansson,et al.  Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. , 2001, Gastroenterology.

[16]  C. Mowat,et al.  Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. , 2000, Gastroenterology.

[17]  T. Koike,et al.  Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylorieradication , 2000, Gut.

[18]  T. Koike,et al.  A new endoscopic method of gastric acid secretory testing , 1998, American Journal of Gastroenterology.

[19]  Y. Shiratori,et al.  Major virulence factors, VacA and CagA, are commonly positive inHelicobacter pylori isolates in Japan , 1998, Gut.

[20]  E. El-Omar,et al.  Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.

[21]  D. Graham,et al.  Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. , 1997, Scandinavian journal of gastroenterology.

[22]  J R Bennett,et al.  The endoscopic assessment of esophagitis: a progress report on observer agreement. , 1996, Gastroenterology.

[23]  E. Kuipers,et al.  Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.

[24]  M. Blaser,et al.  Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[25]  E. El-Omar,et al.  Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. , 1993, Gut.

[26]  T C Campbell,et al.  Geographic association between urinary excretion of N‐nitroso compounds and oesophageal cancer mortality in china , 1993, International journal of cancer.

[27]  D. Graham,et al.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. , 1992, Gastroenterology.

[28]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[29]  C. McConkey,et al.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. , 1990, British Journal of Cancer.

[30]  Kenji Takahashi,et al.  Serum pepsinogens as a screening test of extensive chronic gastritis , 1987, Gastroenterologia Japonica.

[31]  T. Takemoto,et al.  An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .

[32]  P. Hainaut,et al.  The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. , 2007, Best practice & research. Clinical gastroenterology.

[33]  R. Stockbrügger,et al.  Bacteria in the aetio-pathogenesis of gastric cancer: a review. , 1995, Scandinavian journal of gastroenterology. Supplement.